NCT06432075View on ClinicalTrials.gov

Neoantigen Reactive T Cells c for Chinese Patients With Advanced Gastric Cancer

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

January 1, 2026

Study Completion Date

December 1, 2026

Conditions
Advanced Gastric Cancer
Interventions
BIOLOGICAL

Neoantigen Reactive T Cells(NRTs)

Neoantigen Reactive T Cells in an expected volume of 100 milliliter（mL） will be given by intravenous injection over 2-10 minutes through either a peripheral or a central line.

All Listed Sponsors
lead

First Affiliated Hospital of Wenzhou Medical University

OTHER

NCT06432075 - Neoantigen Reactive T Cells c for Chinese Patients With Advanced Gastric Cancer | Biotech Hunter | Biotech Hunter